These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25384907)

  • 41. Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study).
    Balán IC; Giguere R; Lentz C; Kutner BA; Kajura-Manyindo C; Byogero R; Asiimwe FB; Makala Y; Jambaya J; Khanyile N; Chetty D; Soto-Torres L; Mayo A; Mgodi NM; Palanee-Phillips T; Baeten JM
    AIDS Behav; 2021 Feb; 25(2):447-458. PubMed ID: 32833192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007).
    Leu CS; Mabragaña M; Giguere R; Dolezal C; Carballo-Diéguez A; McGowan I
    AIDS Behav; 2013 Nov; 17(9):3101-7. PubMed ID: 23842718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Debrief Reports to Expedite the Impact of Qualitative Research: Do They Accurately Capture Data from In-depth Interviews?
    Simoni JM; Beima-Sofie K; Amico KR; Hosek SG; Johnson MO; Mensch BS
    AIDS Behav; 2019 Aug; 23(8):2185-2189. PubMed ID: 30666522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How patient experience informed the SafeMed Program: Lessons learned during a Health Care Innovation Award to improve care for super-utilizers.
    Nault Connors JD; Binkley BL; Graff JC; Surbhi S; Bailey JE
    Healthc (Amst); 2019 Mar; 7(1):13-21. PubMed ID: 29477610
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation and training of medication adherence counselors in a clinical trial: application of a skill inventory to video-recorded interviews.
    Russell ML; Insull W
    Control Clin Trials; 1981 Jun; 2(2):133-48. PubMed ID: 6168427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erratum to: Sharing of Investigational Drug Among Participants in the Voice Trial.
    Moodley J; Naidoo S; Moodley J; Ramjee G
    AIDS Behav; 2016 Nov; 20(11):2715-2716. PubMed ID: 27246279
    [No Abstract]   [Full Text] [Related]  

  • 47. Offline: Strengthening the voice of medicine in society.
    Horton R
    Lancet; 2020 Sep; 396(10252):656. PubMed ID: 32891196
    [No Abstract]   [Full Text] [Related]  

  • 48. Tenofovir-based preexposure prophylaxis for HIV infection among African women.
    Marrazzo JM; Ramjee G; Richardson BA; Gomez K; Mgodi N; Nair G; Palanee T; Nakabiito C; van der Straten A; Noguchi L; Hendrix CW; Dai JY; Ganesh S; Mkhize B; Taljaard M; Parikh UM; Piper J; Mâsse B; Grossman C; Rooney J; Schwartz JL; Watts H; Marzinke MA; Hillier SL; McGowan IM; Chirenje ZM;
    N Engl J Med; 2015 Feb; 372(6):509-18. PubMed ID: 25651245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pre-exposure Prophylaxis Adherence Measured by Plasma Drug Level in MTN-001: Comparison Between Vaginal Gel and Oral Tablets in Two Geographic Regions.
    Minnis AM; van der Straten A; Salee P; Hendrix CW
    AIDS Behav; 2016 Jul; 20(7):1541-8. PubMed ID: 25969178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucosal effects of tenofovir 1% gel.
    Hladik F; Burgener A; Ballweber L; Gottardo R; Vojtech L; Fourati S; Dai JY; Cameron MJ; Strobl J; Hughes SM; Hoesley C; Andrew P; Johnson S; Piper J; Friend DR; Ball TB; Cranston RD; Mayer KH; McElrath MJ; McGowan I
    Elife; 2015 Feb; 4():. PubMed ID: 25647729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.
    Pattacini L; Murnane PM; Baeten JM; Fluharty TR; Thomas KK; Bukusi E; Katabira E; Mugo N; Donnell D; Lingappa JR; Celum C; Marzinke M; McElrath MJ; Lund JM;
    J Infect Dis; 2015 Jun; 211(12):1943-52. PubMed ID: 25520426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facilitators of adherence to the study pill in the FEM-PrEP clinical trial.
    Corneli A; Perry B; Agot K; Ahmed K; Malamatsho F; Van Damme L
    PLoS One; 2015; 10(4):e0125458. PubMed ID: 25867624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills.
    Corneli AL; McKenna K; Perry B; Ahmed K; Agot K; Malamatsho F; Skhosana J; Odhiambo J; Van Damme L
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):578-84. PubMed ID: 25761233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana.
    Toledo L; McLellan-Lemal E; Henderson FL; Kebaabetswe PM
    World J AIDS; 2015 Mar; 5(2):10-20. PubMed ID: 26767149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya.
    Carroll JJ; Ngure K; Heffron R; Curran K; Mugo NR; Baeten JM
    AIDS Care; 2016 Aug; 28(8):1000-6. PubMed ID: 26754017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women.
    Burns RN; Hendrix CW; Chaturvedula A
    J Clin Pharmacol; 2015 Jun; 55(6):629-38. PubMed ID: 25581815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP.
    Corneli A; Wang M; Agot K; Ahmed K; Lombaard J; Van Damme L;
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):555-63. PubMed ID: 25393942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.
    Chen BA; Panther L; Marzinke MA; Hendrix CW; Hoesley CJ; van der Straten A; Husnik MJ; Soto-Torres L; Nel A; Johnson S; Richardson-Harman N; Rabe LK; Dezzutti CS
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):242-9. PubMed ID: 26034880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors associated with bone mineral density in healthy African women.
    Mgodi NM; Kelly C; Gati B; Greenspan S; Dai JY; Bragg V; Livant E; Piper JM; Nakabiito C; Magure T; Marrazzo JM; Chirenje ZM; Riddler SA;
    Arch Osteoporos; 2015; 10():206. PubMed ID: 25680424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.